O
GERN icon

OrbiMed’s Geron GERN Stock Holding History

OrbiMed’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,168,000
Closed -$7.67M – 114
2024
Q4 		$7.67M Buy
+2,168,000
New +$8.66M 0.16% 75
2024
Q3 		– Sell
-8,930,252
Closed -$40.6M – 125
2024
Q2 		$37.9M Sell
8,930,252
-3,963,359
-31% -$15.5M 0.75% 43
2024
Q1 		$42.5M Buy
12,893,611
+12,408,611
+2,558% +$27.8M 0.78% 43
2023
Q4 		$1.02M Buy
+485,000
New +$943K 0.02% 104

Other funds holding GERN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed's GERN Position: Q1 2025 in Review

OrbiMed sold out of Geron (GERN) in Q1 2025, closing a stake of 2,168,000 shares — an estimated $7.67M sold.

OrbiMed first reported a position in GERN in Q4 2023 and held it in 4 quarters. The position peaked at $42.5M in Q1 2024. 270 funds tracked by Wall St. Rank hold GERN as of Q1 2025.

  • OrbiMed reported no remaining Geron position as of Q1 2025 after selling out during the quarter.
  • OrbiMed sold 2,168,000 Geron shares in Q1 2025, an estimated $7.67M.
  • OrbiMed first reported a position in Geron in Q4 2023 and held it in 4 quarters.
  • OrbiMed's Geron position peaked at $42.5M in Q1 2024.
  • 270 funds tracked by Wall St. Rank held Geron as of Q1 2025.

Based on OrbiMed's 13F filing for Q1 2025, filed 15 May 2025.